Skip to content

Observation of ImageReady™ MR Conditional Pacing System in China

Observation of ImageReady™ MR Conditional Pacing System in China

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02636712
Enrollment
10
Registered
2015-12-22
Start date
2015-12-08
Completion date
2017-11-30
Last updated
2020-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arhythmia, Atrioventricular Heart-block, Carotid Sinus Hypersensitivity Reaction Syndrome, Chronic Bundle Branch or Branch Block, Vasovagal Syncope

Brief summary

To observe the safety and efficacy of ImageReady™ MR Conditional Pacing System in Chinese subjects

Detailed description

Key Inclusion Criteria: 1. Subject must have the Image Ready System as their initial (de novo) pacing system implant. 2. Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines. 3. Subject is able and willing to undergo an MR scan.• 4. Subject is willing and capable of providing informed consent and participating in all testing/ visits associated with this clinical study at the intervals defined by this protocol. 5. Subject is age 18 or above. Key Exclusion Criteria 1. Subject has or has had any pacing or ICD system implants. 2. Subject has any implants or devices that are not suitable for MR scan. 3. Subject is enrolled in any other concurrent study that might interfere with this study. 4. Subject has documented life expectancy of less than 12 months. 5. Women of childbearing potential who are or might be pregnant at the time of this study. Primary Safety Endpoint: MR Scan related Complication Free Rate Analyzed at MRI Visit +1 Month. Primary efficacy Endpoint: 1. Pacing Threshold (at 0.5 ms pulse width) comparison pre and 1 Month post MR Scan: pacing threshold increase ≤ 0.5 V after scan. 2. Sensed Amplitude comparison pre- and 1 Month post-MR Scan: sensed amplitude: ≥ 1.0 mV after scan, and ≥ 50% of that before scan.

Interventions

DEVICEImageReady™ MR Conditional Pacing System

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must have the ImageReady System as their initial (de novo) pacing system implant * Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines5 * Subject is able and willing to undergo an MR scan * Subject is willing and capable of providing informed consent and participating in all testing/ visits associated with this clinical study at the intervals defined by this protocol * Subject is age 18 or above

Exclusion criteria

* Subject has or has had any pacing or ICD system implants * Subject has any implants or devices that are not suitable for MR scan * Subject is enrolled in any other concurrent study that might interfere with this study * Subject has documented life expectancy of less than 12 months * Women of childbearing potential who are or might be pregnant at the time of this study

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants Without Complications at MRI Visit + 1 Month.Within 1 month after the Pacemaker been implanted.No one has any complications related MR Scan . So Complication-Free rate is 100%.
Percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) From Pre-MR Scan to MRI Visit + 1 Month Follow-upPre-MR scan and 1 Month post-MR Scan.The percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) from Pre-MR Scan to MRI Visit + 1 Month Follow-up is 100 percent.
Percentage of Participants With Atrial Sensed Amplitude at the MRI Visit + 1 Month Follow up Remains ≥ 1.0 mV and Above 50% of the Pre-MR Scan ValuePre-MR scan and 1 Month post-MR Scan.The Percentage of participants with atrial sensed amplitude at the MRI Visit + 1 Month Follow up remains ≥ 1.0 mV and above 50% of the pre-MR scan value is 100%.
Percentage of Participants With Ventricular Sensed Amplitudes at the MRI Visit + 1 Month Follow up Remains ≥ 5.0 mV and Above 50% of the Pre-MR Scan.Pre-MR scan and 1 Month post-MR Scan.The percentage of participants with ventricular sensed amplitudes at the MRI Visit + 1 Month Follow up remains ≥ 5.0 mV and above 50% of the pre-MR scan is 100%.

Secondary

MeasureTime frameDescription
Percentage of Participants Without System-related ComplicationsWithin 3 months after the Pacemaker been implanted.No one has any complications related system occurred. So Complication-Free rate is 100%.

Countries

China

Participant flow

Recruitment details

The recruitment has finished on 25 Dec 2015 and totally 10 patients.

Participants by arm

ArmCount
ImageReady™ System Indication
1. Subject must have the ImageReady™ System as their initial (de novo) pacing system implant 2. Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines ImageReady™ MR Conditional Pacing System
10
Total10

Baseline characteristics

CharacteristicImageReady™ System Indication
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
8 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
Age, Continuous69.4 Year
Region of Enrollment
China
10 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
2 / 10
serious
Total, serious adverse events
1 / 10

Outcome results

Primary

Percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) From Pre-MR Scan to MRI Visit + 1 Month Follow-up

The percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) from Pre-MR Scan to MRI Visit + 1 Month Follow-up is 100 percent.

Time frame: Pre-MR scan and 1 Month post-MR Scan.

ArmMeasureValue (NUMBER)
ImageReady™ MR System IndicationPercentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) From Pre-MR Scan to MRI Visit + 1 Month Follow-up100 percentage of participants
Primary

Percentage of Participants With Atrial Sensed Amplitude at the MRI Visit + 1 Month Follow up Remains ≥ 1.0 mV and Above 50% of the Pre-MR Scan Value

The Percentage of participants with atrial sensed amplitude at the MRI Visit + 1 Month Follow up remains ≥ 1.0 mV and above 50% of the pre-MR scan value is 100%.

Time frame: Pre-MR scan and 1 Month post-MR Scan.

ArmMeasureValue (NUMBER)
ImageReady™ MR System IndicationPercentage of Participants With Atrial Sensed Amplitude at the MRI Visit + 1 Month Follow up Remains ≥ 1.0 mV and Above 50% of the Pre-MR Scan Value100 percentage of paticipants
Primary

Percentage of Participants Without Complications at MRI Visit + 1 Month.

No one has any complications related MR Scan . So Complication-Free rate is 100%.

Time frame: Within 1 month after the Pacemaker been implanted.

ArmMeasureValue (NUMBER)
ImageReady™ MR System IndicationPercentage of Participants Without Complications at MRI Visit + 1 Month.100 percentage of paticipants
Primary

Percentage of Participants With Ventricular Sensed Amplitudes at the MRI Visit + 1 Month Follow up Remains ≥ 5.0 mV and Above 50% of the Pre-MR Scan.

The percentage of participants with ventricular sensed amplitudes at the MRI Visit + 1 Month Follow up remains ≥ 5.0 mV and above 50% of the pre-MR scan is 100%.

Time frame: Pre-MR scan and 1 Month post-MR Scan.

ArmMeasureValue (NUMBER)
ImageReady™ MR System IndicationPercentage of Participants With Ventricular Sensed Amplitudes at the MRI Visit + 1 Month Follow up Remains ≥ 5.0 mV and Above 50% of the Pre-MR Scan.100 percentage of paticipants
Secondary

Percentage of Participants Without System-related Complications

No one has any complications related system occurred. So Complication-Free rate is 100%.

Time frame: Within 3 months after the Pacemaker been implanted.

ArmMeasureValue (NUMBER)
ImageReady™ MR System IndicationPercentage of Participants Without System-related Complications100 percentage of paticipants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026